Behandlingen - injiceres subkutant dagligt i 7 dage, efterfulgt af en hvileperiode på 21 dage (28 dages behandlingscyklus).
Posology The recommended starting dose for the first treatment cycle, for all patients regardless of baseline haematology laboratory values, is 75 mg/ m2 of body surface area, injected subcutaneously, daily for 7 days, followed by a rest period of 21 days (28-day treatment cycle).